WCM Investment Management CA lifted its holdings in shares of MAXIMUS, Inc. (NYSE:MMS) by 463.2% in the fourth quarter, Holdings Channel reports. The fund owned 152,155 shares of the health services provider’s stock after acquiring an additional 125,139 shares during the period. WCM Investment Management CA’s holdings in MAXIMUS were worth $10,891,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also modified their holdings of MMS. JPMorgan Chase & Co. increased its position in shares of MAXIMUS by 459.2% during the second quarter. JPMorgan Chase & Co. now owns 25,842 shares of the health services provider’s stock valued at $1,619,000 after acquiring an additional 21,221 shares during the last quarter. New York State Common Retirement Fund increased its position in shares of MAXIMUS by 10.0% during the second quarter. New York State Common Retirement Fund now owns 86,332 shares of the health services provider’s stock valued at $5,407,000 after acquiring an additional 7,815 shares during the last quarter. UBS Asset Management Americas Inc. increased its position in MAXIMUS by 1.7% in the second quarter. UBS Asset Management Americas Inc. now owns 34,898 shares of the health services provider’s stock worth $2,186,000 after buying an additional 592 shares during the last quarter. California Public Employees Retirement System increased its position in MAXIMUS by 2.7% in the second quarter. California Public Employees Retirement System now owns 99,900 shares of the health services provider’s stock worth $6,257,000 after buying an additional 2,600 shares during the last quarter. Finally, Voya Investment Management LLC increased its position in MAXIMUS by 10.9% in the second quarter. Voya Investment Management LLC now owns 29,734 shares of the health services provider’s stock worth $1,862,000 after buying an additional 2,932 shares during the last quarter. 96.44% of the stock is owned by institutional investors.

MAXIMUS, Inc. (MMS) opened at $65.24 on Thursday. The company has a market capitalization of $4,224.52, a price-to-earnings ratio of 20.52, a PEG ratio of 2.43 and a beta of 1.21. MAXIMUS, Inc. has a twelve month low of $51.74 and a twelve month high of $72.71.

MAXIMUS (NYSE:MMS) last posted its quarterly earnings data on Thursday, November 9th. The health services provider reported $0.81 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.77 by $0.04. The company had revenue of $620.90 million during the quarter, compared to analyst estimates of $606.86 million. MAXIMUS had a return on equity of 23.97% and a net margin of 8.54%. equities analysts predict that MAXIMUS, Inc. will post 3.05 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, February 28th. Shareholders of record on Thursday, February 15th will be paid a dividend of $0.045 per share. This represents a $0.18 annualized dividend and a yield of 0.28%. The ex-dividend date of this dividend is Wednesday, February 14th. MAXIMUS’s dividend payout ratio (DPR) is currently 5.66%.

In other MAXIMUS news, Director Russell A. Beliveau sold 1,500 shares of MAXIMUS stock in a transaction dated Wednesday, November 15th. The stock was sold at an average price of $64.30, for a total transaction of $96,450.00. Following the completion of the sale, the director now owns 40,329 shares of the company’s stock, valued at $2,593,154.70. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, General Counsel David Francis sold 3,900 shares of MAXIMUS stock in a transaction dated Monday, November 13th. The stock was sold at an average price of $63.97, for a total value of $249,483.00. Following the sale, the general counsel now directly owns 15,090 shares of the company’s stock, valued at approximately $965,307.30. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 71,417 shares of company stock valued at $4,902,785. Corporate insiders own 3.10% of the company’s stock.

A number of analysts have issued reports on MMS shares. Canaccord Genuity decreased their target price on MAXIMUS from $62.00 to $61.00 and set a “hold” rating for the company in a research report on Friday, November 10th. Zacks Investment Research lowered MAXIMUS from a “hold” rating to a “sell” rating in a report on Tuesday, November 14th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $65.60.

TRADEMARK VIOLATION NOTICE: “MAXIMUS, Inc. (MMS) Shares Bought by WCM Investment Management CA” was posted by Daily Political and is the property of of Daily Political. If you are reading this report on another site, it was stolen and republished in violation of international trademark and copyright legislation. The legal version of this report can be read at https://www.dailypolitical.com/2018/02/08/maximus-inc-mms-shares-bought-by-wcm-investment-management-ca.html.

About MAXIMUS

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MAXIMUS, Inc. (NYSE:MMS).

Institutional Ownership by Quarter for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.